Contact Us
Drug Search Results
More Filters [+]

Tulobuterol

Alternative Names: tulobuterol
Latest Update: 2024-03-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ADRB2 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Transdermal,Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | Brazil | Colombia | Ecuador | India | Italy | Korea | Pakistan | Philippines | Portugal | South Africa | Turkey | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Teikoku Pharma USA
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tulobuterol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Chronic Obstructive Pulmonary Disease

Phase 2: Airway Obstruction|Asthma|Parkinson's Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CTR20242657

N/A

Completed

Asthma|Dyspnea|Bronchitis, Chronic|Emphysema

2024-06-22

NCT04057469

N/A

Completed

Anesthesia Related|Tonsillitis

2021-09-30

2020-003796-17

P2

Unknown status

Parkinson's Disease

2021-02-21

CTR20202310

N/A

Completed

Asthma|Bronchitis, Chronic|Dyspnea|Emphysema

2020-12-21

Recent News Events

Date

Type

Title

03/01/2024

PubMed

 Rhamnose-PEG-induced supramolecular helices: Addressing challenges of drug solubility and release efficiency in transdermal patch.

03/01/2024

PubMed

 Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.

12/01/2023

PubMed

 [Determination of 14 β-agonists in animal meat by ultra high performance liquid chromatography-tandem mass spectrometry].

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions